Effect of linagliptin compared with glimepiride on postprandial glucose metabolism, islet cell function and vascular function parameters in patients with type 2 diabetes mellitus receiving ongoing metformin treatment. [electronic resource]
Producer: 20150622Description: 582-9 p. digitalISSN:- 1520-7560
- Aged
- Biomarkers -- blood
- Blood Glucose -- metabolism
- Cardiovascular Diseases -- epidemiology
- Diabetes Mellitus, Type 2 -- complications
- Drug Therapy, Combination
- Female
- Glucagon -- blood
- Glucagon-Like Peptide 1 -- blood
- Humans
- Hypoglycemic Agents -- pharmacology
- Insulin -- blood
- Islets of Langerhans -- drug effects
- Linagliptin
- Male
- Metformin -- therapeutic use
- Middle Aged
- Plasminogen Activator Inhibitor 1 -- blood
- Postprandial Period -- physiology
- Proinsulin -- blood
- Purines -- pharmacology
- Quinazolines -- pharmacology
- Risk Factors
- Sulfonylurea Compounds -- pharmacology
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.